CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections

por Chaudhary, Manu, Ayub, Shiekh Gazalla, Mir, Mohd Amin
Publicado 2018

Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a p...

por Chaudhary, Manu, Mir, Mohd Amin, Ayub, Shiekh Gazalla
Publicado 2017

Reduced nitrate level in individuals with hypertension and diabetes

por Shiekh, Gazalla Ayub, Ayub, Taha, Khan, Saquib Naveed, Dar, Rubiya, Andrabi, Khurshid Iqbal
Publicado 2011

A novel G26A variation in 5′ half of TGIF1 gene associates with high myopia in ethnic Kashmiri population from India

por Rasool, Shabhat, Dar, Rubiya, Bhat, Arif Akbar, Ayub, Shiekh Gazalla, Rehman, Muneeb U, Rashid, Sabia, Jan, Tariq, Andrabi, Khursheed Iqbal
Publicado 2019

1959. Ceftriaxone-Sulbactam-EDTA (CSE) vs. Meropenem (MR) in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes in Patients Infected With Ceftriaxone Non-Susceptible, Exten...

por Mir, Mohd Amin, Chaudhary, Saransh, Mammen, Kim Jacob, Sood, Rajeev, Dogra, P N, Chadha, Sudhir, Mavuduru, Ravimohan, Sinha, Rahul Janak, Chaudhary, Manu, Shiekh, Gazalla
Publicado 2018